Resection of colorectal liver metastases

Current perspectives

James Mcloughlin, Eric H. Jensen, Mokenge Malafa

Research output: Contribution to journalReview article

60 Citations (Scopus)

Abstract

Background: Metastases to the liver is the leading cause of death in patients with colorectal cancer. Methods: The authors review the data on diagnosis and management of this clinical problem, and they discuss management options that can be considered. Results: Complete surgical resection of metastases from colorectal cancer that are localized to the liver results in 5-year survival rates ranging from 26% to 40%. Conclusions: By adding modalities such as targeted systemic therapy and other "local" treatments for liver metastases, further gains in survival are anticipated.

Original languageEnglish (US)
Pages (from-to)32-41
Number of pages10
JournalCancer Control
Volume13
Issue number1
DOIs
StatePublished - Jan 1 2006
Externally publishedYes

Fingerprint

Neoplasm Metastasis
Colorectal Neoplasms
Liver
Cause of Death
Survival Rate
Survival
Therapeutics

All Science Journal Classification (ASJC) codes

  • Hematology
  • Oncology

Cite this

Resection of colorectal liver metastases : Current perspectives. / Mcloughlin, James; Jensen, Eric H.; Malafa, Mokenge.

In: Cancer Control, Vol. 13, No. 1, 01.01.2006, p. 32-41.

Research output: Contribution to journalReview article

Mcloughlin, James ; Jensen, Eric H. ; Malafa, Mokenge. / Resection of colorectal liver metastases : Current perspectives. In: Cancer Control. 2006 ; Vol. 13, No. 1. pp. 32-41.
@article{4ddb730d04f446f3a5373c7cd5283daa,
title = "Resection of colorectal liver metastases: Current perspectives",
abstract = "Background: Metastases to the liver is the leading cause of death in patients with colorectal cancer. Methods: The authors review the data on diagnosis and management of this clinical problem, and they discuss management options that can be considered. Results: Complete surgical resection of metastases from colorectal cancer that are localized to the liver results in 5-year survival rates ranging from 26{\%} to 40{\%}. Conclusions: By adding modalities such as targeted systemic therapy and other {"}local{"} treatments for liver metastases, further gains in survival are anticipated.",
author = "James Mcloughlin and Jensen, {Eric H.} and Mokenge Malafa",
year = "2006",
month = "1",
day = "1",
doi = "10.1177/107327480601300105",
language = "English (US)",
volume = "13",
pages = "32--41",
journal = "Cancer Control",
issn = "1073-2748",
publisher = "H. Lee Moffitt Cancer Center and Research Institute",
number = "1",

}

TY - JOUR

T1 - Resection of colorectal liver metastases

T2 - Current perspectives

AU - Mcloughlin, James

AU - Jensen, Eric H.

AU - Malafa, Mokenge

PY - 2006/1/1

Y1 - 2006/1/1

N2 - Background: Metastases to the liver is the leading cause of death in patients with colorectal cancer. Methods: The authors review the data on diagnosis and management of this clinical problem, and they discuss management options that can be considered. Results: Complete surgical resection of metastases from colorectal cancer that are localized to the liver results in 5-year survival rates ranging from 26% to 40%. Conclusions: By adding modalities such as targeted systemic therapy and other "local" treatments for liver metastases, further gains in survival are anticipated.

AB - Background: Metastases to the liver is the leading cause of death in patients with colorectal cancer. Methods: The authors review the data on diagnosis and management of this clinical problem, and they discuss management options that can be considered. Results: Complete surgical resection of metastases from colorectal cancer that are localized to the liver results in 5-year survival rates ranging from 26% to 40%. Conclusions: By adding modalities such as targeted systemic therapy and other "local" treatments for liver metastases, further gains in survival are anticipated.

UR - http://www.scopus.com/inward/record.url?scp=33644638369&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33644638369&partnerID=8YFLogxK

U2 - 10.1177/107327480601300105

DO - 10.1177/107327480601300105

M3 - Review article

VL - 13

SP - 32

EP - 41

JO - Cancer Control

JF - Cancer Control

SN - 1073-2748

IS - 1

ER -